Upcoming events, conferences, webinars and virtual exhibitions of Nuray Chemicals Private Limited

PharmaCompass

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Related CompaniesRelated Companies

About

Established in 2012, Nuray Chemicals Pvt Ltd is an API manufacturer for highly regulated markets. Its manufacturing facility with state-of-the-art R&D is located near Chennai in the Indian state of Tamil Nadu. Nuray’s expertise and experience lie in developing the chemistry requirements of the pharmaceutical industry, including the synthesis of NCEs, impurities, metabolites, method development, advanced intermediates and APIs for commercial launch. With its focus on maintaining the highest levels of quality, reliability and transparency, Nuray has emerged as a trusted partner in the global generic market.

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
India
Address
Address
Plot No . 111, SIDCO Industrial Estate, Kakkalur, Thiruvallur, Tamilnadu 602 0...
Telephone
Telephone
+91 4466616700
youtube
YouTube

Events

Webinars & Exhibitions

cphi-worldwide-milan-70313.png

CPhI Worldwide, Milan

Contact Supplier

Meeting

Digital content read-more

Explore the latest content creation from this company

CORPORATE CONTENT #SupplierSpotlight

    https://www.pharmacompass.com/pdf/party/content/nuray-chemicals-private-limited-party-content-54.pdf

    https://www.pharmacompass.com/pdf/party/content/nuray-chemicals-private-limited-party-content-94357.pdf

    https://www.pharmacompass.com/pdf/party/content/nuray-chemicals-private-limited-party-content-3058.pdf

    https://www.pharmacompass.com/pdf/party/content/nuray-chemicals-private-limited-party-content-62938.pdf

NEWS #PharmaBuzz

read-more
read-more

https://pharmabiz.com/NewsDetails.aspx?aid=99159&sid=11

PHARMABIZ
12 Dec 2016

http://pharmabiz.com/NewsDetails.aspx?aid=90312&sid=1

PHARMABIZ
01 Sep 2015

http://www.pharmabiz.com/NewsDetails.aspx?aid=75290&sid=1

PHARMABIZ
11 May 2013

USDMF

read-more
read-more